Granisetron Market Size, Trends, Analysis, and Outlook By Product (Transdermal system, Injection, Oral), By Application (Chemotherapy, Post-operative), By Distribution Channel (Hospitals, Drug Stores, Others), by Country, Segment, and Companies, 2024-2032
The global Granisetron market size is poised to register 5.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Granisetron market across By Product (Transdermal system, Injection, Oral), By Application (Chemotherapy, Post-operative), By Distribution Channel (Hospitals, Drug Stores, Others)
The Granisetron market is experiencing notable growth driven by the rising incidence of chemotherapy-induced nausea and vomiting (CINV) and the expanding oncology therapeutics landscape. Granisetron, a selective serotonin receptor antagonist, remains a cornerstone in the management of CINV, owing to its efficacy and tolerability profile. Further, advancements in drug delivery systems, such as transdermal patches and extended-release formulations, are enhancing patient convenience and compliance. By 2030, the market is anticipated to witness further growth, propelled by the increasing adoption of multimodal antiemetic regimens and the development of novel combination therapies targeting multiple pathways involved in CINV.
Granisetron Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Granisetron market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Granisetron survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Granisetron industry.
Key market trends defining the global Granisetron demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Granisetron Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Granisetron industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Granisetron companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Granisetron industry
Leading Granisetron companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Granisetron companies.
Granisetron Market Study- Strategic Analysis Review
The Granisetron market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Granisetron industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Granisetron Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Granisetron Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Granisetron market segments. Similarly, Strong market demand is encouraging Canadian Granisetron companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Granisetron market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Granisetron Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Granisetron industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Granisetron market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Granisetron Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Granisetron in Asia Pacific. In particular, China, India, and South East Asian Granisetron markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Granisetron Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Granisetron Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Granisetron market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Granisetron.
Granisetron Market Company Profiles
The global Granisetron market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Akorn Operating Company LLC, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Fresenius SE & Co. KGaA, Heron Therapeutics Inc, Hikma Pharmaceuticals PLC, Kyowa Kirin Co. Ltd, Merck KGaA, Natco Pharma Ltd, Novartis AG, Viatris Inc.
Recent Granisetron Market Developments
The global Granisetron market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Granisetron Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Transdermal system
Injection
Oral
By Application
Chemotherapy
Post-operative
By Distribution Channel
Hospitals
Drug Stores
Others
Geographical Segmentation:
Akorn Operating Company LLC
Cipla Ltd
Dr. Reddy's Laboratories Ltd
Fresenius SE & Co. KGaA
Heron Therapeutics Inc
Hikma Pharmaceuticals PLC
Kyowa Kirin Co. Ltd
Merck KGaA
Natco Pharma Ltd
Novartis AG
Viatris Inc
Formats Available: Excel, PDF, and PPT
The Granisetron market is experiencing notable growth driven by the rising incidence of chemotherapy-induced nausea and vomiting (CINV) and the expanding oncology therapeutics landscape. Granisetron, a selective serotonin receptor antagonist, remains a cornerstone in the management of CINV, owing to its efficacy and tolerability profile. Further, advancements in drug delivery systems, such as transdermal patches and extended-release formulations, are enhancing patient convenience and compliance. By 2030, the market is anticipated to witness further growth, propelled by the increasing adoption of multimodal antiemetic regimens and the development of novel combination therapies targeting multiple pathways involved in CINV.
Granisetron Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Granisetron market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Granisetron survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Granisetron industry.
Key market trends defining the global Granisetron demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Granisetron Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Granisetron industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Granisetron companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Granisetron industry
Leading Granisetron companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Granisetron companies.
Granisetron Market Study- Strategic Analysis Review
The Granisetron market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Granisetron industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Granisetron Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Granisetron Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Granisetron market segments. Similarly, Strong market demand is encouraging Canadian Granisetron companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Granisetron market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Granisetron Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Granisetron industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Granisetron market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Granisetron Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Granisetron in Asia Pacific. In particular, China, India, and South East Asian Granisetron markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Granisetron Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Granisetron Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Granisetron market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Granisetron.
Granisetron Market Company Profiles
The global Granisetron market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Akorn Operating Company LLC, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Fresenius SE & Co. KGaA, Heron Therapeutics Inc, Hikma Pharmaceuticals PLC, Kyowa Kirin Co. Ltd, Merck KGaA, Natco Pharma Ltd, Novartis AG, Viatris Inc.
Recent Granisetron Market Developments
The global Granisetron market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Granisetron Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Transdermal system
Injection
Oral
By Application
Chemotherapy
Post-operative
By Distribution Channel
Hospitals
Drug Stores
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Akorn Operating Company LLC
Cipla Ltd
Dr. Reddy's Laboratories Ltd
Fresenius SE & Co. KGaA
Heron Therapeutics Inc
Hikma Pharmaceuticals PLC
Kyowa Kirin Co. Ltd
Merck KGaA
Natco Pharma Ltd
Novartis AG
Viatris Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Granisetron Market Overview and Key Findings, 2024
1.2 Granisetron Market Size and Growth Outlook, 2021- 2030
1.3 Granisetron Market Growth Opportunities to 2030
1.4 Key Granisetron Market Trends and Challenges
1.4.1 Granisetron Market Drivers and Trends
1.4.2 Granisetron Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Granisetron Companies
2. GRANISETRON MARKET SIZE OUTLOOK TO 2030
2.1 Granisetron Market Size Outlook, USD Million, 2021- 2030
2.2 Granisetron Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GRANISETRON MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GRANISETRON MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Transdermal system
Injection
Oral
By Application
Chemotherapy
Post-operative
By Distribution Channel
Hospitals
Drug Stores
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Granisetron Market, 2025
5.2 Asia Pacific Granisetron Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Granisetron Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Granisetron Market, 2025
5.5 Europe Granisetron Market Size Outlook by Type, 2021- 2030
5.6 Europe Granisetron Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Granisetron Market, 2025
5.8 North America Granisetron Market Size Outlook by Type, 2021- 2030
5.9 North America Granisetron Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Granisetron Market, 2025
5.11 South America Pacific Granisetron Market Size Outlook by Type, 2021- 2030
5.12 South America Granisetron Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Granisetron Market, 2025
5.14 Middle East Africa Granisetron Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Granisetron Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Granisetron Market Size Outlook and Revenue Growth Forecasts
6.2 US Granisetron Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Granisetron Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Granisetron Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Granisetron Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Granisetron Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Granisetron Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Granisetron Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Granisetron Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Granisetron Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Granisetron Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Granisetron Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Granisetron Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Granisetron Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Granisetron Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Granisetron Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Granisetron Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Granisetron Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Granisetron Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Granisetron Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Granisetron Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Granisetron Industry Drivers and Opportunities
7. GRANISETRON MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GRANISETRON COMPANY PROFILES
8.1 Profiles of Leading Granisetron Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Akorn Operating Company LLC
Cipla Ltd
Dr. Reddy's Laboratories Ltd
Fresenius SE & Co. KGaA
Heron Therapeutics Inc
Hikma Pharmaceuticals PLC
Kyowa Kirin Co. Ltd
Merck KGaA
Natco Pharma Ltd
Novartis AG
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Granisetron Market Overview and Key Findings, 2024
1.2 Granisetron Market Size and Growth Outlook, 2021- 2030
1.3 Granisetron Market Growth Opportunities to 2030
1.4 Key Granisetron Market Trends and Challenges
1.4.1 Granisetron Market Drivers and Trends
1.4.2 Granisetron Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Granisetron Companies
2. GRANISETRON MARKET SIZE OUTLOOK TO 2030
2.1 Granisetron Market Size Outlook, USD Million, 2021- 2030
2.2 Granisetron Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GRANISETRON MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GRANISETRON MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Transdermal system
Injection
Oral
By Application
Chemotherapy
Post-operative
By Distribution Channel
Hospitals
Drug Stores
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Granisetron Market, 2025
5.2 Asia Pacific Granisetron Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Granisetron Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Granisetron Market, 2025
5.5 Europe Granisetron Market Size Outlook by Type, 2021- 2030
5.6 Europe Granisetron Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Granisetron Market, 2025
5.8 North America Granisetron Market Size Outlook by Type, 2021- 2030
5.9 North America Granisetron Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Granisetron Market, 2025
5.11 South America Pacific Granisetron Market Size Outlook by Type, 2021- 2030
5.12 South America Granisetron Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Granisetron Market, 2025
5.14 Middle East Africa Granisetron Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Granisetron Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Granisetron Market Size Outlook and Revenue Growth Forecasts
6.2 US Granisetron Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Granisetron Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Granisetron Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Granisetron Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Granisetron Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Granisetron Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Granisetron Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Granisetron Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Granisetron Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Granisetron Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Granisetron Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Granisetron Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Granisetron Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Granisetron Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Granisetron Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Granisetron Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Granisetron Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Granisetron Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Granisetron Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Granisetron Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Granisetron Industry Drivers and Opportunities
7. GRANISETRON MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GRANISETRON COMPANY PROFILES
8.1 Profiles of Leading Granisetron Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Akorn Operating Company LLC
Cipla Ltd
Dr. Reddy's Laboratories Ltd
Fresenius SE & Co. KGaA
Heron Therapeutics Inc
Hikma Pharmaceuticals PLC
Kyowa Kirin Co. Ltd
Merck KGaA
Natco Pharma Ltd
Novartis AG
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
